Clinical Trial 44041

New Port Richey, FL 34652


Summary:

This is a randomized, double-blinded, placebo-controlled, Phase 3 study to evaluate the efficacy and safety of tildrakizumab compared to placebo in subjects with active PsA


Qualified Participants Must:

• Be 18 Years and older
• Have a diagnosis of active PsA for at least 6 months


Qualified Participants May Receive:

Study Drug: One 1 mL injection of study medication

or 

Matching placebo injections: One 1 mL injection of placebo

 

Payment for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.